Legend Biotech Corporation - ADR
News
Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by TD Asset Management Inc
Ticker Report TD Asset Management Inc cut its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 24.4% during the second quarter, according to the company in its most recent filing with the...\n more…
Brokerages Set Legend Biotech Co. (NASDAQ:LEGN) Price Target at $81.78
Ticker Report Shares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have been assigned a consensus recommendation of "Buy" from the thirteen brokerages that are covering the firm, MarketBeat.com reports...\n more…
LEGN Makes Notable Cross Below Critical Moving Average
Market News Video In trading on Thursday, shares of Legend Biotech Corp (LEGN) crossed below their 200 day moving average of 54.66, changing hands as low as 53.91 per share. Legend Biotech Corp shares are...\n more…
Legend Biotech (NASDAQ:LEGN) Receives "Buy" Rating from HC Wainwright
Ticker Report HC Wainwright reiterated their buy rating on shares of Legend Biotech (NASDAQ:LEGN - Free Report) in a report released on Wednesday, Benzinga reports. They currently have a $73.00 price target on the...\n more…
Beyond The Numbers: 14 Analysts Discuss Legend Biotech Stock
Benzinga 14 analysts have shared their evaluations of Legend Biotech LEGN during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.\n more…